EichorEICHOR
Condition: Primary Generalized Seizure Synced from ClinicalTrials.gov · August 04, 2026

Recruiting studies: Primary Generalized Seizure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastas
Phase 2 · 1 location(s) · Ayal A. Aizer, MD · NCT07130786An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Phase 2 · 11 location(s) · Praxis Precision Medicines · NCT06908356A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Phase 3 · 138 location(s) · Xenon Pharmaceuticals Inc. · NCT05667142ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
Phase 3 · 25 location(s) · Ono Pharmaceutical Co., Ltd. · NCT06579573Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
NA · 1 location(s) · Mayo Clinic · NCT07012148A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized T
Phase N/A · 1 location(s) · Eisai Co., Ltd. · NCT06657378
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.